OceansBio Co Ltd
332190
Company Profile
Business description
OceansBio Co Ltd engaged in the manufacture and sale of medical devices. The company's flagship product is TaVNS that helps people suffering from neurological disorders alleviate their conditions by delivering electrical impulses to the vagus nerve.
Contact
46 Changwon-daero 18beon-gil, Uichang-gu
320, 3rd floor
Changwon-si
Gyeongsangnam-do
KORT: +82 27172640
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Will undervalued ASX share show progress in results?
Investors will get to see if the new strategy and capital management framework are working.
stocks
10 best US dividend aristocrats to buy now for 2026
These undervalued stocks with economic moats have increased their dividends for 25 consecutive years or more.
stocks
What to expect from the January Fed meeting
Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,268.50 | 94.30 | 1.03% |
| CAC 40 | 8,164.45 | 33.30 | 0.41% |
| DAX 40 | 24,915.71 | 17.37 | -0.07% |
| Dow JONES (US) | 49,412.40 | 313.69 | 0.64% |
| FTSE 100 | 10,215.04 | 66.19 | 0.65% |
| HKSE | 27,126.95 | 361.43 | 1.35% |
| NASDAQ | 23,601.36 | 100.11 | 0.43% |
| Nikkei 225 | 53,333.54 | 448.29 | 0.85% |
| NZX 50 Index | 13,510.88 | 50.14 | 0.37% |
| S&P 500 | 6,950.23 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,941.60 | 96.50 | 1.09% |
| SSE Composite Index | 4,139.90 | 7.30 | 0.18% |